185 related articles for article (PubMed ID: 9179815)
1. Feline leukaemia virus: a review of immunity and vaccination.
Sparkes AH
J Small Anim Pract; 1997 May; 38(5):187-94. PubMed ID: 9179815
[TBL] [Abstract][Full Text] [Related]
2. Feline leukemia virus immunity induced by whole inactivated virus vaccination.
Torres AN; O'Halloran KP; Larson LJ; Schultz RD; Hoover EA
Vet Immunol Immunopathol; 2010 Mar; 134(1-2):122-31. PubMed ID: 20004483
[TBL] [Abstract][Full Text] [Related]
3. Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression.
Patel M; Carritt K; Lane J; Jayappa H; Stahl M; Bourgeois M
Clin Vaccine Immunol; 2015 Jul; 22(7):798-805. PubMed ID: 25972402
[TBL] [Abstract][Full Text] [Related]
4. Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell 2 vaccine.
Harbour DA; Gunn-Moore DA; Gruffydd-Jones TJ; Caney SM; Bradshaw J; Jarrett O; Wiseman A
Vaccine; 2002 Jul; 20(23-24):2866-72. PubMed ID: 12126896
[TBL] [Abstract][Full Text] [Related]
5. Feline leukaemia virus (FeLV) and feline immunodeficiency virus infections in cats in the Pisa district of Tuscany, and attempts to control FeLV infection in a colony of domestic cats by vaccination.
Bandecchi P; Dell'Omodarme M; Magi M; Palamidessi A; Prati MC
Vet Rec; 2006 Apr; 158(16):555-7. PubMed ID: 16632529
[TBL] [Abstract][Full Text] [Related]
6. Vaccination against the feline leukaemia virus: outcome and response categories and long-term follow-up.
Hofmann-Lehmann R; Cattori V; Tandon R; Boretti FS; Meli ML; Riond B; Pepin AC; Willi B; Ossent P; Lutz H
Vaccine; 2007 Jul; 25(30):5531-9. PubMed ID: 17240486
[TBL] [Abstract][Full Text] [Related]
7. A vector expressing feline mature IL-18 fused to IL-1beta antagonist protein signal sequence is an effective adjuvant to a DNA vaccine for feline leukaemia virus.
O'Donovan LH; McMonagle EL; Taylor S; Bain D; Pacitti AM; Golder MC; McDonald M; Hanlon L; Onions DE; Argyle DJ; Jarrett O; Nicolson L
Vaccine; 2005 May; 23(29):3814-23. PubMed ID: 15893619
[TBL] [Abstract][Full Text] [Related]
8. No benefit of therapeutic vaccination in clinically healthy cats persistently infected with feline leukemia virus.
Helfer-Hungerbuehler AK; Spiri AM; Riond B; Grest P; Boretti FS; Hofmann-Lehmann R
Vaccine; 2015 Mar; 33(13):1578-85. PubMed ID: 25698488
[TBL] [Abstract][Full Text] [Related]
9. Feline leukaemia virus: protective immunity is mediated by virus-specific cytotoxic T lymphocytes.
Flynn JN; Hanlon L; Jarrett O
Immunology; 2000 Sep; 101(1):120-5. PubMed ID: 11012762
[TBL] [Abstract][Full Text] [Related]
10. Immunization with the transmembrane protein of a retrovirus, feline leukemia virus: absence of antigenemia following challenge.
Langhammer S; Hübner J; Jarrett O; Kurth R; Denner J
Antiviral Res; 2011 Jan; 89(1):119-23. PubMed ID: 21108970
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of feline leukemia virus vaccines.
Legendre AM
J Am Vet Med Assoc; 1994 Jul; 205(1):28. PubMed ID: 7928542
[No Abstract] [Full Text] [Related]
12. Weakly coupled hyperbolic systems modeling the circulation of FeLV in structured feline populations.
Fitzgibbon WE; Langlais M
Math Biosci; 2000 May; 165(1):79-95. PubMed ID: 10804261
[TBL] [Abstract][Full Text] [Related]
13. FeLV vaccination.
Mainland TR
Vet Rec; 1993 Nov; 133(20):508. PubMed ID: 8296439
[No Abstract] [Full Text] [Related]
14. Feline leukaemia virus.
J Small Anim Pract; 1998 Jan; 39(1):41-3. PubMed ID: 9494934
[No Abstract] [Full Text] [Related]
15. Characterization of neutrophil extracellular traps in cats naturally infected with feline leukemia virus.
Wardini AB; Guimarães-Costa AB; Nascimento MT; Nadaes NR; Danelli MG; Mazur C; Benjamim CF; Saraiva EM; Pinto-da-Silva LH
J Gen Virol; 2010 Jan; 91(Pt 1):259-64. PubMed ID: 19793908
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of an inactivated feline leukemia virus vaccine.
Hoover EA; Mullins JI; Chu HJ; Wasmoen TL
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):379-83. PubMed ID: 8882314
[TBL] [Abstract][Full Text] [Related]
17. Recombinant feline leukemia virus (FeLV) variants establish a limited infection with altered cell tropism in specific-pathogen-free cats in the absence of FeLV subgroup A helper virus.
Bechtel MK; Hayes KA; Mathes LE; Pandey R; Stromberg PC; Roy-Burman P
Vet Pathol; 1999 Mar; 36(2):91-9. PubMed ID: 10098636
[TBL] [Abstract][Full Text] [Related]
18. Feline leukemia vaccine: efficacy, contents and probable mechanism.
Mastro JM; Lewis MG; Mathes LE; Sharpee R; Tarr MJ; Olsen RG
Vet Immunol Immunopathol; 1986 Mar; 11(3):205-13. PubMed ID: 3008410
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppression in a Comparative Study of Feline Leukemia Virus Vaccines.
Poulet H; Thibault JC; Masias A
Clin Vaccine Immunol; 2015 Dec; 22(12):1294-5. PubMed ID: 26604264
[No Abstract] [Full Text] [Related]
20. Reply to "Immunosuppression in a Comparative Study of Feline Leukemia Virus Vaccines".
Patel M; Carritt K; Lane J; Jayappa H; Stahl M; Bourgeois M
Clin Vaccine Immunol; 2015 Dec; 22(12):1296-7. PubMed ID: 26604265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
